
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Share this page To
TREATMENT VIDEO + ARTICLE: There’s good news about the investigational drug Lecanemab: a Phase 3 clinical trial showed the anti-amyloid beta antibody slows cognitive decline
INSPIRING VIDEO:
Over the years, this video has lifted thousands with Alzheimer’s. David Gary Quinton speaks candidly about his life with dementia. See how he and his wife stay upbeat and prepare for changes ahead. Hear Quinton talk passionately about his decision to maximize life and live it to the fullest.
Lecanemab is today’s #1 Alzheimer’s antibody. (Brand name: Leqembi) Washington University researchers found Lecanemab’s adverse events to be rare and manageable in very mild or mild Alzheimer’s.
DIET VIDEO + ARTICLE: Walnuts fight Alzheimer’s in a big way in the lab. Learn how walnuts appear to have a beneficial effect in reducing risk, delaying onset, slowing progression and preventing Alzheimer’s.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Visit Alzheimer's Weekly On